GeneReach Biotechnology Corp. total revenue, net income and dynamics of changes in Taiwan new dollar today
GeneReach Biotechnology Corp. net revenue for today is 275 583 000 $. Net income of GeneReach Biotechnology Corp. today amounted to 109 730 000 $. Here are the main financial indicators of GeneReach Biotechnology Corp.. Chart of online financial report of GeneReach Biotechnology Corp.. GeneReach Biotechnology Corp. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of GeneReach Biotechnology Corp. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of GeneReach Biotechnology Corp. finance reports: 31/12/2018, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of GeneReach Biotechnology Corp. for today is 30/06/2021. Gross profit GeneReach Biotechnology Corp. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit GeneReach Biotechnology Corp. is 214 690 000 $
Cost of revenue GeneReach Biotechnology Corp. is the total cost of producing and distributing of products and services of a company. Cost of revenue GeneReach Biotechnology Corp. is 60 893 000 $ Total revenue GeneReach Biotechnology Corp. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue GeneReach Biotechnology Corp. is 275 583 000 $ Operating income GeneReach Biotechnology Corp. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income GeneReach Biotechnology Corp. is 142 688 000 $
Net income GeneReach Biotechnology Corp. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income GeneReach Biotechnology Corp. is 109 730 000 $ Current assets GeneReach Biotechnology Corp. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets GeneReach Biotechnology Corp. is 967 974 000 $ Total assets GeneReach Biotechnology Corp. refers to the total amount of assets owned by a person or entity. Total assets GeneReach Biotechnology Corp. is 1 454 614 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 988 435 591.34 $
5 941 748 990.01 $
6 287 508 749.90 $
4 821 789 443.89 $
2 195 681 894.56 $
2 256 324 940.38 $
2 566 343 388.24 $
1 220 119 853.14 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 982 145 458.40 $
1 628 052 569.29 $
2 982 674 336.18 $
1 233 823 944.54 $
400 055 304.94 $
254 095 338.52 $
236 029 374.79 $
588 527 250.88 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
8 970 581 049.74 $
7 569 801 559.30 $
9 270 183 086.08 $
6 055 613 388.44 $
2 595 737 199.50 $
2 510 420 278.89 $
2 802 372 763.03 $
1 808 647 104.02 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
4 644 677 896.77 $
3 838 903 363.12 $
4 009 179 140.19 $
2 697 622 724.68 $
735 528 858.46 $
755 027 078.77 $
861 632 540.42 $
-23 925 195.21 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
3 571 852 612.78 $
3 028 864 611.01 $
2 961 581 102.85 $
2 223 415 590.23 $
591 294 110.19 $
763 783 374.70 $
666 357 375.71 $
68 683 213.46 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
460 112 427.61 $
471 993 647 $
424 957 038.73 $
450 509 798.24 $
325 968 578 $
278 020 533.73 $
325 317 552.28 $
253 053 697.36 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 325 903 152.97 $
3 730 898 196.18 $
5 261 003 945.89 $
3 357 990 663.76 $
1 860 208 341.04 $
1 755 393 200.12 $
1 940 740 222.61 $
1 832 572 299.23 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
31 508 798 514.56 $
28 946 816 998.65 $
25 996 824 153.61 $
21 004 693 830.08 $
11 648 835 759.25 $
11 912 794 137.42 $
11 182 961 754.01 $
14 085 006 554.77 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
47 349 556 333.60 $
43 150 017 272.89 $
40 380 065 590.72 $
35 531 681 746.16 $
23 225 179 804.57 $
23 204 672 494.39 $
22 264 037 982.85 $
22 585 026 214.09 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
11 549 456 683.09 $
12 599 268 207.87 $
10 210 687 392.48 $
8 968 432 664.86 $
5 000 723 863.04 $
4 642 171 447.75 $
4 264 348 671.14 $
3 239 471 431.43 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 999 039 575.83 $
3 205 715 747.85 $
6 360 749 143.40 $
12 121 740 842.25 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
4 692 202 774.33 $
5 948 877 721.64 $
9 058 241 662.94 $
12 456 758 677.77 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
20.20 %
25.64 %
40.69 %
55.15 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
33 016 476 428.23 $
29 478 151 640.03 $
26 464 683 787.29 $
23 473 415 911.61 $
17 569 784 477.50 $
16 325 283 711.15 $
12 247 616 665.22 $
9 402 308 755.96 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-677 815 428.38 $
-235 052 836.21 $
-468 836 172.26 $
275 188 571.84 $
Last revenue report of GeneReach Biotechnology Corp. was 30/06/2021. According to last financial report total revenue in GeneReach Biotechnology Corp. was 8 970 581 049.74 Taiwan new dollar and changed by +257.33% since last year. Net income in GeneReach Biotechnology Corp. was 3 571 852 612.78 $ in last quartal, net income changes to +367.65%.
Current cash GeneReach Biotechnology Corp. - the sum of all of the cash a company has on the date of report. Current cash GeneReach Biotechnology Corp. is 354 808 000 $
